Similar articles

• A comparison between BC 105 and methysergide in the prophylaxis of migraine.

  Forssman B, Henriksson KG, Kihlstrand S. Forssman B, et al. Acta Neurol Scand. 1972;48(2):204-12. doi: 10.1111/j.1600-0404.1972.tb07541.x. Acta Neurol Scand. 1972. PMID: 4556413 Clinical Trial. No abstract available.
• A comparative trial of serotonin antagonists in the management of migraine.

  Lance JW, Anthony M. Lance JW, et al. Proc Aust Assoc Neurol. 1970;7:31-5. Proc Aust Assoc Neurol. 1970. PMID: 4937096 Clinical Trial. No abstract available.
• Pizotifen (BC-105): a review of its pharmacological properties and its therapeutic efficacy in vascular headaches.

  Speight TM, Avery GS. Speight TM, et al. Drugs. 1972;3(3):159-203. doi: 10.2165/00003495-197203030-00002. Drugs. 1972. PMID: 4403890 Review. No abstract available.
• [Clinical experiences with polyantiaminic BC-105 Sandoz in the prevention of vasomotor headaches].

  Sercl M, Vrcha L. Sercl M, et al. Schweiz Rundsch Med Prax. 1970 May 5;59(18):679-83. Schweiz Rundsch Med Prax. 1970. PMID: 4396441 Clinical Trial. German. No abstract available.
• Current concepts in the pathogenesis and interval treatment of migraine.

  Anthony M, Lance JW. Anthony M, et al. Drugs. 1972;3(3):153-8. doi: 10.2165/00003495-197203030-00001. Drugs. 1972. PMID: 4403461 Review. No abstract available.